プラスミドDNA CDMOのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Plasmid DNA CDMO Market Insights, Forecast to 2028

• レポートコード：QY2203B05560
• 出版社/出版日：QYResearch / 2022年3月
• レポート形態：英文、PDF、113ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界のプラスミドDNA CDMOの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にプラスミドDNA CDMOの世界市場のxxx％を占める「GMPグレードプラスミドDNA」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「DNAワクチン」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のプラスミドDNA CDMOの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのプラスミドDNA CDMO市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのプラスミドDNA CDMO市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

プラスミドDNA CDMOのグローバル主要メーカーには、GenScript ProBio、Biovian、Biomay、VGXI、Esco Aster、Delphi Genetics、Richter-Helm BioLogics、Cytovance Biologics、Cobra Biologics、Obiosh、Thermo Fisher、Aldevron(Danaher)、Cognate BioServices (Charles River Laboratories)、Pharmaron Inc.、Porton、WuXi AppTec、AGC Biologicsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

プラスミドDNA CDMO市場は、種類と用途によって区分されます。世界のプラスミドDNA CDMO市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
GMPグレードプラスミドDNA、ノンGMPグレードプラスミドDNA

【用途別セグメント】
DNAワクチン、遺伝子治療、免疫療法、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- プラスミドDNA CDMO製品概要
- 種類別市場（GMPグレードプラスミドDNA、ノンGMPグレードプラスミドDNA）
- 用途別市場（DNAワクチン、遺伝子治療、免疫療法、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のプラスミドDNA CDMO販売量予測2017-2028
- 世界のプラスミドDNA CDMO売上予測2017-2028
- プラスミドDNA CDMOの地域別販売量
- プラスミドDNA CDMOの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別プラスミドDNA CDMO販売量
- 主要メーカー別プラスミドDNA CDMO売上
- 主要メーカー別プラスミドDNA CDMO価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（GMPグレードプラスミドDNA、ノンGMPグレードプラスミドDNA）
- プラスミドDNA CDMOの種類別販売量
- プラスミドDNA CDMOの種類別売上
- プラスミドDNA CDMOの種類別価格
・用途別市場規模（DNAワクチン、遺伝子治療、免疫療法、その他）
- プラスミドDNA CDMOの用途別販売量
- プラスミドDNA CDMOの用途別売上
- プラスミドDNA CDMOの用途別価格
・北米市場
- 北米のプラスミドDNA CDMO市場規模（種類別、用途別）
- 主要国別のプラスミドDNA CDMO市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのプラスミドDNA CDMO市場規模（種類別、用途別）
- 主要国別のプラスミドDNA CDMO市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のプラスミドDNA CDMO市場規模（種類別、用途別）
- 主要国別のプラスミドDNA CDMO市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のプラスミドDNA CDMO市場規模（種類別、用途別）
- 主要国別のプラスミドDNA CDMO市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのプラスミドDNA CDMO市場規模（種類別、用途別）
- 主要国別のプラスミドDNA CDMO市場規模（トルコ、サウジアラビア）
・企業情報
GenScript ProBio、Biovian、Biomay、VGXI、Esco Aster、Delphi Genetics、Richter-Helm BioLogics、Cytovance Biologics、Cobra Biologics、Obiosh、Thermo Fisher、Aldevron(Danaher)、Cognate BioServices (Charles River Laboratories)、Pharmaron Inc.、Porton、WuXi AppTec、AGC Biologics
・産業チェーン及び販売チャネル分析
- プラスミドDNA CDMOの産業チェーン分析
- プラスミドDNA CDMOの原材料
- プラスミドDNA CDMOの生産プロセス
- プラスミドDNA CDMOの販売及びマーケティング
- プラスミドDNA CDMOの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- プラスミドDNA CDMOの産業動向
- プラスミドDNA CDMOのマーケットドライバー
- プラスミドDNA CDMOの課題
- プラスミドDNA CDMOの阻害要因
・主な調査結果

Market Analysis and Insights: Global Plasmid DNA CDMO Market
The global Plasmid DNA CDMO market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, GMP Grade Plasmid DNA accounting for % of the Plasmid DNA CDMO global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While DNA Vaccines segment is altered to an % CAGR throughout this forecast period.
China Plasmid DNA CDMO market size is valued at US$ million in 2021, while the North America and Europe Plasmid DNA CDMO are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Plasmid DNA CDMO landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Plasmid DNA CDMO market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Plasmid DNA CDMO market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Plasmid DNA CDMO market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Plasmid DNA CDMO market.
Global Plasmid DNA CDMO Scope and Market Size
Plasmid DNA CDMO market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Plasmid DNA CDMO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
GMP Grade Plasmid DNA
Non-GMP Grade Plasmid DNA
Segment by Application
DNA Vaccines
Gene Therapy
Immunotherapy
Others
By Company
GenScript ProBio
Biovian
Biomay
VGXI
Esco Aster
Delphi Genetics
Richter-Helm BioLogics
Cytovance Biologics
Cobra Biologics
Obiosh
Thermo Fisher
Aldevron(Danaher)
Cognate BioServices (Charles River Laboratories)
Pharmaron Inc.
Porton
WuXi AppTec
AGC Biologics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid DNA CDMO Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 GMP Grade Plasmid DNA
1.2.3 Non-GMP Grade Plasmid DNA
1.3 Market by Application
1.3.1 Global Plasmid DNA CDMO Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 DNA Vaccines
1.3.3 Gene Therapy
1.3.4 Immunotherapy
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Plasmid DNA CDMO Market Perspective (2017-2028)
2.2 Plasmid DNA CDMO Growth Trends by Region
2.2.1 Plasmid DNA CDMO Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Plasmid DNA CDMO Historic Market Size by Region (2017-2022)
2.2.3 Plasmid DNA CDMO Forecasted Market Size by Region (2023-2028)
2.3 Plasmid DNA CDMO Market Dynamics
2.3.1 Plasmid DNA CDMO Industry Trends
2.3.2 Plasmid DNA CDMO Market Drivers
2.3.3 Plasmid DNA CDMO Market Challenges
2.3.4 Plasmid DNA CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmid DNA CDMO Players by Revenue
3.1.1 Global Top Plasmid DNA CDMO Players by Revenue (2017-2022)
3.1.2 Global Plasmid DNA CDMO Revenue Market Share by Players (2017-2022)
3.2 Global Plasmid DNA CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasmid DNA CDMO Revenue
3.4 Global Plasmid DNA CDMO Market Concentration Ratio
3.4.1 Global Plasmid DNA CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid DNA CDMO Revenue in 2021
3.5 Plasmid DNA CDMO Key Players Head office and Area Served
3.6 Key Players Plasmid DNA CDMO Product Solution and Service
3.7 Date of Enter into Plasmid DNA CDMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmid DNA CDMO Breakdown Data by Type
4.1 Global Plasmid DNA CDMO Historic Market Size by Type (2017-2022)
4.2 Global Plasmid DNA CDMO Forecasted Market Size by Type (2023-2028)
5 Plasmid DNA CDMO Breakdown Data by Application
5.1 Global Plasmid DNA CDMO Historic Market Size by Application (2017-2022)
5.2 Global Plasmid DNA CDMO Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Plasmid DNA CDMO Market Size (2017-2028)
6.2 North America Plasmid DNA CDMO Market Size by Type
6.2.1 North America Plasmid DNA CDMO Market Size by Type (2017-2022)
6.2.2 North America Plasmid DNA CDMO Market Size by Type (2023-2028)
6.2.3 North America Plasmid DNA CDMO Market Share by Type (2017-2028)
6.3 North America Plasmid DNA CDMO Market Size by Application
6.3.1 North America Plasmid DNA CDMO Market Size by Application (2017-2022)
6.3.2 North America Plasmid DNA CDMO Market Size by Application (2023-2028)
6.3.3 North America Plasmid DNA CDMO Market Share by Application (2017-2028)
6.4 North America Plasmid DNA CDMO Market Size by Country
6.4.1 North America Plasmid DNA CDMO Market Size by Country (2017-2022)
6.4.2 North America Plasmid DNA CDMO Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Plasmid DNA CDMO Market Size (2017-2028)
7.2 Europe Plasmid DNA CDMO Market Size by Type
7.2.1 Europe Plasmid DNA CDMO Market Size by Type (2017-2022)
7.2.2 Europe Plasmid DNA CDMO Market Size by Type (2023-2028)
7.2.3 Europe Plasmid DNA CDMO Market Share by Type (2017-2028)
7.3 Europe Plasmid DNA CDMO Market Size by Application
7.3.1 Europe Plasmid DNA CDMO Market Size by Application (2017-2022)
7.3.2 Europe Plasmid DNA CDMO Market Size by Application (2023-2028)
7.3.3 Europe Plasmid DNA CDMO Market Share by Application (2017-2028)
7.4 Europe Plasmid DNA CDMO Market Size by Country
7.4.1 Europe Plasmid DNA CDMO Market Size by Country (2017-2022)
7.4.2 Europe Plasmid DNA CDMO Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasmid DNA CDMO Market Size (2017-2028)
8.2 Asia-Pacific Plasmid DNA CDMO Market Size by Type
8.2.1 Asia-Pacific Plasmid DNA CDMO Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Plasmid DNA CDMO Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Plasmid DNA CDMO Market Share by Type (2017-2028)
8.3 Asia-Pacific Plasmid DNA CDMO Market Size by Application
8.3.1 Asia-Pacific Plasmid DNA CDMO Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Plasmid DNA CDMO Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Plasmid DNA CDMO Market Share by Application (2017-2028)
8.4 Asia-Pacific Plasmid DNA CDMO Market Size by Region
8.4.1 Asia-Pacific Plasmid DNA CDMO Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Plasmid DNA CDMO Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Plasmid DNA CDMO Market Size (2017-2028)
9.2 Latin America Plasmid DNA CDMO Market Size by Type
9.2.1 Latin America Plasmid DNA CDMO Market Size by Type (2017-2022)
9.2.2 Latin America Plasmid DNA CDMO Market Size by Type (2023-2028)
9.2.3 Latin America Plasmid DNA CDMO Market Share by Type (2017-2028)
9.3 Latin America Plasmid DNA CDMO Market Size by Application
9.3.1 Latin America Plasmid DNA CDMO Market Size by Application (2017-2022)
9.3.2 Latin America Plasmid DNA CDMO Market Size by Application (2023-2028)
9.3.3 Latin America Plasmid DNA CDMO Market Share by Application (2017-2028)
9.4 Latin America Plasmid DNA CDMO Market Size by Country
9.4.1 Latin America Plasmid DNA CDMO Market Size by Country (2017-2022)
9.4.2 Latin America Plasmid DNA CDMO Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmid DNA CDMO Market Size (2017-2028)
10.2 Middle East & Africa Plasmid DNA CDMO Market Size by Type
10.2.1 Middle East & Africa Plasmid DNA CDMO Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Plasmid DNA CDMO Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Plasmid DNA CDMO Market Share by Type (2017-2028)
10.3 Middle East & Africa Plasmid DNA CDMO Market Size by Application
10.3.1 Middle East & Africa Plasmid DNA CDMO Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Plasmid DNA CDMO Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Plasmid DNA CDMO Market Share by Application (2017-2028)
10.4 Middle East & Africa Plasmid DNA CDMO Market Size by Country
10.4.1 Middle East & Africa Plasmid DNA CDMO Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Plasmid DNA CDMO Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GenScript ProBio
11.1.1 GenScript ProBio Company Details
11.1.2 GenScript ProBio Business Overview
11.1.3 GenScript ProBio Plasmid DNA CDMO Introduction
11.1.4 GenScript ProBio Revenue in Plasmid DNA CDMO Business (2017-2022)
11.1.5 GenScript ProBio Recent Developments
11.2 Biovian
11.2.1 Biovian Company Details
11.2.2 Biovian Business Overview
11.2.3 Biovian Plasmid DNA CDMO Introduction
11.2.4 Biovian Revenue in Plasmid DNA CDMO Business (2017-2022)
11.2.5 Biovian Recent Developments
11.3 Biomay
11.3.1 Biomay Company Details
11.3.2 Biomay Business Overview
11.3.3 Biomay Plasmid DNA CDMO Introduction
11.3.4 Biomay Revenue in Plasmid DNA CDMO Business (2017-2022)
11.3.5 Biomay Recent Developments
11.4 VGXI
11.4.1 VGXI Company Details
11.4.2 VGXI Business Overview
11.4.3 VGXI Plasmid DNA CDMO Introduction
11.4.4 VGXI Revenue in Plasmid DNA CDMO Business (2017-2022)
11.4.5 VGXI Recent Developments
11.5 Esco Aster
11.5.1 Esco Aster Company Details
11.5.2 Esco Aster Business Overview
11.5.3 Esco Aster Plasmid DNA CDMO Introduction
11.5.4 Esco Aster Revenue in Plasmid DNA CDMO Business (2017-2022)
11.5.5 Esco Aster Recent Developments
11.6 Delphi Genetics
11.6.1 Delphi Genetics Company Details
11.6.2 Delphi Genetics Business Overview
11.6.3 Delphi Genetics Plasmid DNA CDMO Introduction
11.6.4 Delphi Genetics Revenue in Plasmid DNA CDMO Business (2017-2022)
11.6.5 Delphi Genetics Recent Developments
11.7 Richter-Helm BioLogics
11.7.1 Richter-Helm BioLogics Company Details
11.7.2 Richter-Helm BioLogics Business Overview
11.7.3 Richter-Helm BioLogics Plasmid DNA CDMO Introduction
11.7.4 Richter-Helm BioLogics Revenue in Plasmid DNA CDMO Business (2017-2022)
11.7.5 Richter-Helm BioLogics Recent Developments
11.8 Cytovance Biologics
11.8.1 Cytovance Biologics Company Details
11.8.2 Cytovance Biologics Business Overview
11.8.3 Cytovance Biologics Plasmid DNA CDMO Introduction
11.8.4 Cytovance Biologics Revenue in Plasmid DNA CDMO Business (2017-2022)
11.8.5 Cytovance Biologics Recent Developments
11.9 Cobra Biologics
11.9.1 Cobra Biologics Company Details
11.9.2 Cobra Biologics Business Overview
11.9.3 Cobra Biologics Plasmid DNA CDMO Introduction
11.9.4 Cobra Biologics Revenue in Plasmid DNA CDMO Business (2017-2022)
11.9.5 Cobra Biologics Recent Developments
11.10 Obiosh
11.10.1 Obiosh Company Details
11.10.2 Obiosh Business Overview
11.10.3 Obiosh Plasmid DNA CDMO Introduction
11.10.4 Obiosh Revenue in Plasmid DNA CDMO Business (2017-2022)
11.10.5 Obiosh Recent Developments
11.11 Thermo Fisher
11.11.1 Thermo Fisher Company Details
11.11.2 Thermo Fisher Business Overview
11.11.3 Thermo Fisher Plasmid DNA CDMO Introduction
11.11.4 Thermo Fisher Revenue in Plasmid DNA CDMO Business (2017-2022)
11.11.5 Thermo Fisher Recent Developments
11.12 Aldevron(Danaher)
11.12.1 Aldevron(Danaher) Company Details
11.12.2 Aldevron(Danaher) Business Overview
11.12.3 Aldevron(Danaher) Plasmid DNA CDMO Introduction
11.12.4 Aldevron(Danaher) Revenue in Plasmid DNA CDMO Business (2017-2022)
11.12.5 Aldevron(Danaher) Recent Developments
11.13 Cognate BioServices (Charles River Laboratories)
11.13.1 Cognate BioServices (Charles River Laboratories) Company Details
11.13.2 Cognate BioServices (Charles River Laboratories) Business Overview
11.13.3 Cognate BioServices (Charles River Laboratories) Plasmid DNA CDMO Introduction
11.13.4 Cognate BioServices (Charles River Laboratories) Revenue in Plasmid DNA CDMO Business (2017-2022)
11.13.5 Cognate BioServices (Charles River Laboratories) Recent Developments
11.14 Pharmaron Inc.
11.14.1 Pharmaron Inc. Company Details
11.14.2 Pharmaron Inc. Business Overview
11.14.3 Pharmaron Inc. Plasmid DNA CDMO Introduction
11.14.4 Pharmaron Inc. Revenue in Plasmid DNA CDMO Business (2017-2022)
11.14.5 Pharmaron Inc. Recent Developments
11.15 Porton
11.15.1 Porton Company Details
11.15.2 Porton Business Overview
11.15.3 Porton Plasmid DNA CDMO Introduction
11.15.4 Porton Revenue in Plasmid DNA CDMO Business (2017-2022)
11.15.5 Porton Recent Developments
11.16 WuXi AppTec
11.16.1 WuXi AppTec Company Details
11.16.2 WuXi AppTec Business Overview
11.16.3 WuXi AppTec Plasmid DNA CDMO Introduction
11.16.4 WuXi AppTec Revenue in Plasmid DNA CDMO Business (2017-2022)
11.16.5 WuXi AppTec Recent Developments
11.17 AGC Biologics
11.17.1 AGC Biologics Company Details
11.17.2 AGC Biologics Business Overview
11.17.3 AGC Biologics Plasmid DNA CDMO Introduction
11.17.4 AGC Biologics Revenue in Plasmid DNA CDMO Business (2017-2022)
11.17.5 AGC Biologics Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Plasmid DNA CDMO Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of GMP Grade Plasmid DNA
Table 3. Key Players of Non-GMP Grade Plasmid DNA
Table 4. Global Plasmid DNA CDMO Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Plasmid DNA CDMO Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Plasmid DNA CDMO Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Plasmid DNA CDMO Market Share by Region (2017-2022)
Table 8. Global Plasmid DNA CDMO Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Plasmid DNA CDMO Market Share by Region (2023-2028)
Table 10. Plasmid DNA CDMO Market Trends
Table 11. Plasmid DNA CDMO Market Drivers
Table 12. Plasmid DNA CDMO Market Challenges
Table 13. Plasmid DNA CDMO Market Restraints
Table 14. Global Plasmid DNA CDMO Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Plasmid DNA CDMO Revenue Share by Players (2017-2022)
Table 16. Global Top Plasmid DNA CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid DNA CDMO as of 2021)
Table 17. Ranking of Global Top Plasmid DNA CDMO Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Plasmid DNA CDMO Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Plasmid DNA CDMO Product Solution and Service
Table 21. Date of Enter into Plasmid DNA CDMO Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Plasmid DNA CDMO Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Plasmid DNA CDMO Revenue Market Share by Type (2017-2022)
Table 25. Global Plasmid DNA CDMO Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Plasmid DNA CDMO Revenue Market Share by Type (2023-2028)
Table 27. Global Plasmid DNA CDMO Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Plasmid DNA CDMO Revenue Share by Application (2017-2022)
Table 29. Global Plasmid DNA CDMO Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Plasmid DNA CDMO Revenue Share by Application (2023-2028)
Table 31. North America Plasmid DNA CDMO Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Plasmid DNA CDMO Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Plasmid DNA CDMO Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Plasmid DNA CDMO Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Plasmid DNA CDMO Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Plasmid DNA CDMO Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Plasmid DNA CDMO Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Plasmid DNA CDMO Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Plasmid DNA CDMO Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Plasmid DNA CDMO Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Plasmid DNA CDMO Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Plasmid DNA CDMO Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Plasmid DNA CDMO Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Plasmid DNA CDMO Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Plasmid DNA CDMO Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Plasmid DNA CDMO Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Plasmid DNA CDMO Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Plasmid DNA CDMO Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Plasmid DNA CDMO Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Plasmid DNA CDMO Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Plasmid DNA CDMO Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Plasmid DNA CDMO Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Plasmid DNA CDMO Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Plasmid DNA CDMO Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Plasmid DNA CDMO Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Plasmid DNA CDMO Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Plasmid DNA CDMO Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Plasmid DNA CDMO Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Plasmid DNA CDMO Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Plasmid DNA CDMO Market Size by Country (2023-2028) & (US$ Million)
Table 61. GenScript ProBio Company Details
Table 62. GenScript ProBio Business Overview
Table 63. GenScript ProBio Plasmid DNA CDMO Product
Table 64. GenScript ProBio Revenue in Plasmid DNA CDMO Business (2017-2022) & (US$ Million)
Table 65. GenScript ProBio Recent Developments
Table 66. Biovian Company Details
Table 67. Biovian Business Overview
Table 68. Biovian Plasmid DNA CDMO Product
Table 69. Biovian Revenue in Plasmid DNA CDMO Business (2017-2022) & (US$ Million)
Table 70. Biovian Recent Developments
Table 71. Biomay Company Details
Table 72. Biomay Business Overview
Table 73. Biomay Plasmid DNA CDMO Product
Table 74. Biomay Revenue in Plasmid DNA CDMO Business (2017-2022) & (US$ Million)
Table 75. Biomay Recent Developments
Table 76. VGXI Company Details
Table 77. VGXI Business Overview
Table 78. VGXI Plasmid DNA CDMO Product
Table 79. VGXI Revenue in Plasmid DNA CDMO Business (2017-2022) & (US$ Million)
Table 80. VGXI Recent Developments
Table 81. Esco Aster Company Details
Table 82. Esco Aster Business Overview
Table 83. Esco Aster Plasmid DNA CDMO Product
Table 84. Esco Aster Revenue in Plasmid DNA CDMO Business (2017-2022) & (US$ Million)
Table 85. Esco Aster Recent Developments
Table 86. Delphi Genetics Company Details
Table 87. Delphi Genetics Business Overview
Table 88. Delphi Genetics Plasmid DNA CDMO Product
Table 89. Delphi Genetics Revenue in Plasmid DNA CDMO Business (2017-2022) & (US$ Million)
Table 90. Delphi Genetics Recent Developments
Table 91. Richter-Helm BioLogics Company Details
Table 92. Richter-Helm BioLogics Business Overview
Table 93. Richter-Helm BioLogics Plasmid DNA CDMO Product
Table 94. Richter-Helm BioLogics Revenue in Plasmid DNA CDMO Business (2017-2022) & (US$ Million)
Table 95. Richter-Helm BioLogics Recent Developments
Table 96. Cytovance Biologics Company Details
Table 97. Cytovance Biologics Business Overview
Table 98. Cytovance Biologics Plasmid DNA CDMO Product
Table 99. Cytovance Biologics Revenue in Plasmid DNA CDMO Business (2017-2022) & (US$ Million)
Table 100. Cytovance Biologics Recent Developments
Table 101. Cobra Biologics Company Details
Table 102. Cobra Biologics Business Overview
Table 103. Cobra Biologics Plasmid DNA CDMO Product
Table 104. Cobra Biologics Revenue in Plasmid DNA CDMO Business (2017-2022) & (US$ Million)
Table 105. Cobra Biologics Recent Developments
Table 106. Obiosh Company Details
Table 107. Obiosh Business Overview
Table 108. Obiosh Plasmid DNA CDMO Product
Table 109. Obiosh Revenue in Plasmid DNA CDMO Business (2017-2022) & (US$ Million)
Table 110. Obiosh Recent Developments
Table 111. Thermo Fisher Company Details
Table 112. Thermo Fisher Business Overview
Table 113. Thermo Fisher Plasmid DNA CDMO Product
Table 114. Thermo Fisher Revenue in Plasmid DNA CDMO Business (2017-2022) & (US$ Million)
Table 115. Thermo Fisher Recent Developments
Table 116. Aldevron(Danaher) Company Details
Table 117. Aldevron(Danaher) Business Overview
Table 118. Aldevron(Danaher) Plasmid DNA CDMO Product
Table 119. Aldevron(Danaher) Revenue in Plasmid DNA CDMO Business (2017-2022) & (US$ Million)
Table 120. Aldevron(Danaher) Recent Developments
Table 121. Cognate BioServices (Charles River Laboratories) Company Details
Table 122. Cognate BioServices (Charles River Laboratories) Business Overview
Table 123. Cognate BioServices (Charles River Laboratories) Plasmid DNA CDMO Product
Table 124. Cognate BioServices (Charles River Laboratories) Revenue in Plasmid DNA CDMO Business (2017-2022) & (US$ Million)
Table 125. Cognate BioServices (Charles River Laboratories) Recent Developments
Table 126. Pharmaron Inc. Company Details
Table 127. Pharmaron Inc. Business Overview
Table 128. Pharmaron Inc. Plasmid DNA CDMO Product
Table 129. Pharmaron Inc. Revenue in Plasmid DNA CDMO Business (2017-2022) & (US$ Million)
Table 130. Pharmaron Inc. Recent Developments
Table 131. Porton Company Details
Table 132. Porton Business Overview
Table 133. Porton Plasmid DNA CDMO Product
Table 134. Porton Revenue in Plasmid DNA CDMO Business (2017-2022) & (US$ Million)
Table 135. Porton Recent Developments
Table 136. WuXi AppTec Company Details
Table 137. WuXi AppTec Business Overview
Table 138. WuXi AppTec Plasmid DNA CDMO Product
Table 139. WuXi AppTec Revenue in Plasmid DNA CDMO Business (2017-2022) & (US$ Million)
Table 140. WuXi AppTec Recent Developments
Table 141. AGC Biologics Company Details
Table 142. AGC Biologics Business Overview
Table 143. AGC Biologics Plasmid DNA CDMO Product
Table 144. AGC Biologics Revenue in Plasmid DNA CDMO Business (2017-2022) & (US$ Million)
Table 145. AGC Biologics Recent Developments
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasmid DNA CDMO Market Share by Type: 2021 VS 2028
Figure 2. GMP Grade Plasmid DNA Features
Figure 3. Non-GMP Grade Plasmid DNA Features
Figure 4. Global Plasmid DNA CDMO Market Share by Application: 2021 VS 2028
Figure 5. DNA Vaccines Case Studies
Figure 6. Gene Therapy Case Studies
Figure 7. Immunotherapy Case Studies
Figure 8. Others Case Studies
Figure 9. Plasmid DNA CDMO Report Years Considered
Figure 10. Global Plasmid DNA CDMO Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Plasmid DNA CDMO Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Plasmid DNA CDMO Market Share by Region: 2021 VS 2028
Figure 13. Global Plasmid DNA CDMO Market Share by Players in 2021
Figure 14. Global Top Plasmid DNA CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasmid DNA CDMO as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Plasmid DNA CDMO Revenue in 2021
Figure 16. North America Plasmid DNA CDMO Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Plasmid DNA CDMO Market Size Market Share by Type (2017-2028)
Figure 18. North America Plasmid DNA CDMO Market Size Market Share by Application (2017-2028)
Figure 19. North America Plasmid DNA CDMO Market Size Share by Country (2017-2028)
Figure 20. United States Plasmid DNA CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Plasmid DNA CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Plasmid DNA CDMO Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Plasmid DNA CDMO Market Size Market Share by Type (2017-2028)
Figure 24. Europe Plasmid DNA CDMO Market Size Market Share by Application (2017-2028)
Figure 25. Europe Plasmid DNA CDMO Market Size Share by Country (2017-2028)
Figure 26. Germany Plasmid DNA CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Plasmid DNA CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Plasmid DNA CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Plasmid DNA CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Plasmid DNA CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Plasmid DNA CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Plasmid DNA CDMO Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Plasmid DNA CDMO Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Plasmid DNA CDMO Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Plasmid DNA CDMO Market Size Share by Region (2017-2028)
Figure 36. China Plasmid DNA CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Plasmid DNA CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Plasmid DNA CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Plasmid DNA CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Plasmid DNA CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Plasmid DNA CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Plasmid DNA CDMO Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Plasmid DNA CDMO Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Plasmid DNA CDMO Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Plasmid DNA CDMO Market Size Share by Country (2017-2028)
Figure 46. Mexico Plasmid DNA CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Plasmid DNA CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Plasmid DNA CDMO Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Plasmid DNA CDMO Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Plasmid DNA CDMO Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Plasmid DNA CDMO Market Size Share by Country (2017-2028)
Figure 52. Turkey Plasmid DNA CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Plasmid DNA CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Plasmid DNA CDMO Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. GenScript ProBio Revenue Growth Rate in Plasmid DNA CDMO Business (2017-2022)
Figure 56. Biovian Revenue Growth Rate in Plasmid DNA CDMO Business (2017-2022)
Figure 57. Biomay Revenue Growth Rate in Plasmid DNA CDMO Business (2017-2022)
Figure 58. VGXI Revenue Growth Rate in Plasmid DNA CDMO Business (2017-2022)
Figure 59. Esco Aster Revenue Growth Rate in Plasmid DNA CDMO Business (2017-2022)
Figure 60. Delphi Genetics Revenue Growth Rate in Plasmid DNA CDMO Business (2017-2022)
Figure 61. Richter-Helm BioLogics Revenue Growth Rate in Plasmid DNA CDMO Business (2017-2022)
Figure 62. Cytovance Biologics Revenue Growth Rate in Plasmid DNA CDMO Business (2017-2022)
Figure 63. Cobra Biologics Revenue Growth Rate in Plasmid DNA CDMO Business (2017-2022)
Figure 64. Obiosh Revenue Growth Rate in Plasmid DNA CDMO Business (2017-2022)
Figure 65. Thermo Fisher Revenue Growth Rate in Plasmid DNA CDMO Business (2017-2022)
Figure 66. Aldevron(Danaher) Revenue Growth Rate in Plasmid DNA CDMO Business (2017-2022)
Figure 67. Cognate BioServices (Charles River Laboratories) Revenue Growth Rate in Plasmid DNA CDMO Business (2017-2022)
Figure 68. Pharmaron Inc. Revenue Growth Rate in Plasmid DNA CDMO Business (2017-2022)
Figure 69. Porton Revenue Growth Rate in Plasmid DNA CDMO Business (2017-2022)
Figure 70. WuXi AppTec Revenue Growth Rate in Plasmid DNA CDMO Business (2017-2022)
Figure 71. AGC Biologics Revenue Growth Rate in Plasmid DNA CDMO Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

TIGIT療法のグローバル市場インサイト・予測（～2028年）

Global TIGIT Therapies Market Insights and Forecast to 2028
QY2203B01140 2022年3月 114Pages
新型コロナウイルス感染症のパンデミックにより、世界のTIGIT療法の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にTIGIT療法の世界市...

アクリル酸2-プロピルヘプチル(2-PHA)のグローバル市場インサイト・予測（～2028年）

Global 2-Propylheptyl Acrylate (2-PHA) Market Insights, Forecast to 2028
QY2203B01339 2022年3月 75Pages
新型コロナウイルス感染症のパンデミックにより、世界のアクリル酸2-プロピルヘプチル(2-PHA)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、20...

1,3-プロパンジオール (PDO)のグローバル市場インサイト・予測（～2028年）

Global 1,3-Propanediol(PDO) Market Insights and Forecast to 2028
QY2203B00031 2022年3月 73Pages
新型コロナウイルス感染症のパンデミックにより、世界の1,3-プロパンジオール (PDO)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に...

ボンディングワニスのグローバル市場インサイト・予測（～2028年）

Global Bonding Varnish Market Insights and Forecast to 2028
QY2203B06330 2022年3月 70Pages
新型コロナウイルス感染症のパンデミックにより、世界のボンディングワニスの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にボンディングワニス...

パルスチェイス解析のグローバル市場インサイト・予測（～2028年）

Global Pulse-chase Analysis Market Insights, Forecast to 2028
QY2203B04973 2022年3月 79Pages
新型コロナウイルス感染症のパンデミックにより、世界のパルスチェイス解析の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にパルスチェイス解析...

パンクレリパーゼのグローバル市場インサイト・予測（～2028年）

Global Pancrelipase Market Insights and Forecast to 2028
QY2203B05040 2022年3月 72Pages
新型コロナウイルス感染症のパンデミックにより、世界のパンクレリパーゼの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にパンクレリパーゼの世...

ジメチルアミノメチルシクロヘキサノンのグローバル市場インサイト・予測（～2028年）

Pages
...

Eインクスクリーンのグローバル市場インサイト・予測（～2028年）

Global E-ink Screens Market Insights and Forecast to 2028
QY2203B00584 2022年3月 72Pages
新型コロナウイルス感染症のパンデミックにより、世界のEインクスクリーンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にEインクスクリーン...

過活動膀胱（OAB）治療のグローバル市場インサイト・予測（～2028年）

Global Overactive Bladder Treatment Market Insights and Forecast to 2028
QY2203B08096 2022年3月 91Pages
新型コロナウイルス感染症のパンデミックにより、世界の過活動膀胱（OAB）治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に過活動膀胱（...

スピンオンドーパントのグローバル市場インサイト・予測（～2028年）

Global Spin-on Dopant Market Insights, Forecast to 2028
QY2203B03540 2022年3月 77Pages
新型コロナウイルス感染症のパンデミックにより、世界のスピンオンドーパントの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にスピンオンドーパ...

幹細胞治療のグローバル市場インサイト・予測（～2028年） Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use. Market Analysis and Insights: Global Stem Cell Therapy Market The global Stem…
オゾン療法パッチのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Ozone Therapy Patch Market Due to the COVID-19 pandemic, the global Ozone Therapy Patch market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully consideri…
ワクチン用等温ボックスのグローバル市場インサイト・予測（～2028年） Cold boxes and small vaccine carriers are products used to keep vaccines cool during transportation. In this report, the superset of cold boxes and vaccine carriers has been considered as isOthersmal boxes. Market Analysis and Insights: Global IsOthersmal Boxes for Vaccines Market Due to the COVID-1…
試薬用塩化カルシウム水和物のグローバル市場インサイト・予測（～2028年） A limescale inhibitor is a unit which doesn’t physically remove Calcuim from the water, but does stop the limescale from causing damage to pipes, boilers, tanks, showers, washing machines and make cleaning easier. Market Analysis and Insights: Global Reagent Grade Calcium Chloride Hydrate Market Due…
医療用PFAのグローバル市場インサイト・予測（～2028年） Perfluoroalkoxy (PFA) is a fully fluorinated translucent, slightly flexible polymer with a low coefficient of friction and outstanding antistick properties. This tough material resists stress cracking and attack by nearly all chemicals and solvents. PFA is also temperature resistant, making it ideal…